Product Liability | Pharmaceutical Litigation | Health Law Depo‑Provera (medroxyprogesterone acetate), a long‑acting injectable progestin approved by the FDA in 1992, has recently come under scrutiny due to mounting evidence suggesting a potential link with intracranial meningioma tumors. This emerging body of medical data has catalyzed an explosion of litigation—including
Tag: health law
Major Setback: SCOTUS Upholds Tennessee Ban on Gender-Affirming Care for Minors
Civil Rights | Health Law | LGBTQ+ Policy In a pivotal 6–3 decision on United States v. Skrmetti, the U.S. Supreme Court upheld Tennessee’s ban on gender-affirming medical care—including puberty blockers and hormone therapy—for transgender minors. The Court found the state’s law constitutional under the Equal Protection Clause, applying rational basis